Financial - Data & Stock Exchanges
Compare Stocks
2 / 10Stock Comparison
MORN vs MSCI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
MORN vs MSCI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $6.38B | $42.38B |
| Revenue (TTM) | $2.45B | $3.13B |
| Net Income (TTM) | $403M | $1.32B |
| Gross Margin | 61.0% | 82.4% |
| Operating Margin | 21.5% | 54.7% |
| Forward P/E | 14.1x | 29.7x |
| Total Debt | $1.41B | $6.31B |
| Cash & Equiv. | $475M | $515M |
MORN vs MSCI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Morningstar, Inc. (MORN) | 100 | 109.4 | +9.4% |
| MSCI Inc. (MSCI) | 100 | 177.0 | +77.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MORN vs MSCI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MORN is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 12 yrs, beta 0.52, yield 1.1%
- Lower volatility, beta 0.52, current ratio 0.99x
- PEG 1.24 vs MSCI's 1.75
MSCI carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 9.7%, EPS growth 10.7%
- 7.2% 10Y total return vs MORN's 120.3%
- 9.7% NII/revenue growth vs MORN's 7.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.7% NII/revenue growth vs MORN's 7.5% | |
| Value | Lower P/E (14.1x vs 29.7x), PEG 1.24 vs 1.75 | |
| Quality / Margins | Efficiency ratio 0.3% vs MORN's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.52 vs MSCI's 0.61 | |
| Dividends | 1.2% yield, 11-year raise streak, vs MORN's 1.1% | |
| Momentum (1Y) | +8.1% vs MORN's -42.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs MORN's 0.4% |
MORN vs MSCI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MORN vs MSCI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MSCI and MORN operate at a comparable scale, with $3.1B and $2.4B in trailing revenue. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to MORN's 15.3%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.4B | $3.1B |
| EBITDAEarnings before interest/tax | $763M | $2.0B |
| Net IncomeAfter-tax profit | $403M | $1.3B |
| Free Cash FlowCash after capex | $437M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +61.0% | +82.4% |
| Operating MarginEBIT ÷ Revenue | +21.5% | +54.7% |
| Net MarginNet income ÷ Revenue | +15.3% | +38.4% |
| FCF MarginFCF ÷ Revenue | +18.1% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +50.0% | +49.1% |
Valuation Metrics
MORN leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 18.9x trailing earnings, MORN trades at a 49% valuation discount to MSCI's 37.4x P/E. Adjusting for growth (PEG ratio), MORN offers better value at 1.66x vs MSCI's 2.21x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $6.4B | $42.4B |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $48.2B |
| Trailing P/EPrice ÷ TTM EPS | 18.90x | 37.41x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.09x | 29.67x |
| PEG RatioP/E ÷ EPS growth rate | 1.66x | 2.21x |
| EV / EBITDAEnterprise value multiple | 10.20x | 24.93x |
| Price / SalesMarket cap ÷ Revenue | 2.61x | 13.52x |
| Price / BookPrice ÷ Book value/share | 5.79x | — |
| Price / FCFMarket cap ÷ FCF | 14.41x | 27.36x |
Profitability & Efficiency
MSCI leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), MSCI scores 8/9 vs MORN's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +30.0% | — |
| ROA (TTM)Return on assets | +10.9% | +24.0% |
| ROICReturn on invested capital | +15.3% | +34.9% |
| ROCEReturn on capital employed | +20.6% | +44.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 |
| Debt / EquityFinancial leverage | 1.15x | — |
| Net DebtTotal debt minus cash | $933M | $5.8B |
| Cash & Equiv.Liquid assets | $475M | $515M |
| Total DebtShort + long-term debt | $1.4B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | 12.40x | 7.67x |
Total Returns (Dividends Reinvested)
MSCI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MSCI five years ago would be worth $12,833 today (with dividends reinvested), compared to $6,723 for MORN. Over the past 12 months, MSCI leads with a +8.1% total return vs MORN's -42.2%. The 3-year compound annual growth rate (CAGR) favors MSCI at 8.4% vs MORN's -2.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -19.8% | +3.4% |
| 1-Year ReturnPast 12 months | -42.2% | +8.1% |
| 3-Year ReturnCumulative with dividends | -7.7% | +27.3% |
| 5-Year ReturnCumulative with dividends | -32.8% | +28.3% |
| 10-Year ReturnCumulative with dividends | +120.3% | +723.8% |
| CAGR (3Y)Annualised 3-year return | -2.6% | +8.4% |
Risk & Volatility
Evenly matched — MORN and MSCI each lead in 1 of 2 comparable metrics.
Risk & Volatility
MORN is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than MSCI's 0.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MSCI currently trades 93.0% from its 52-week high vs MORN's 52.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 0.61x |
| 52-Week HighHighest price in past year | $316.71 | $626.28 |
| 52-Week LowLowest price in past year | $149.08 | $501.08 |
| % of 52W HighCurrent price vs 52-week peak | +52.9% | +93.0% |
| RSI (14)Momentum oscillator 0–100 | 40.9 | 53.9 |
| Avg Volume (50D)Average daily shares traded | 515K | 519K |
Analyst Outlook
Evenly matched — MORN and MSCI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates MORN as "Hold" and MSCI as "Buy". Consensus price targets imply 41.1% upside for MORN (target: $237) vs 15.8% for MSCI (target: $674). For income investors, MSCI offers the higher dividend yield at 1.24% vs MORN's 1.09%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $236.50 | $674.33 |
| # AnalystsCovering analysts | 6 | 27 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +1.2% |
| Dividend StreakConsecutive years of raises | 12 | 11 |
| Dividend / ShareAnnual DPS | $1.82 | $7.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +12.3% | +5.9% |
MSCI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MORN leads in 1 (Valuation Metrics). 2 tied.
MORN vs MSCI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is MORN or MSCI a better buy right now?
For growth investors, MSCI Inc.
(MSCI) is the stronger pick with 9. 7% revenue growth year-over-year, versus 7. 5% for Morningstar, Inc. (MORN). Morningstar, Inc. (MORN) offers the better valuation at 18. 9x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate MSCI Inc. (MSCI) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MORN or MSCI?
On trailing P/E, Morningstar, Inc.
(MORN) is the cheapest at 18. 9x versus MSCI Inc. at 37. 4x. On forward P/E, Morningstar, Inc. is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Morningstar, Inc. wins at 1. 24x versus MSCI Inc. 's 1. 75x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — MORN or MSCI?
Over the past 5 years, MSCI Inc.
(MSCI) delivered a total return of +28. 3%, compared to -32. 8% for Morningstar, Inc. (MORN). Over 10 years, the gap is even starker: MSCI returned +723. 8% versus MORN's +120. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MORN or MSCI?
By beta (market sensitivity over 5 years), Morningstar, Inc.
(MORN) is the lower-risk stock at 0. 52β versus MSCI Inc. 's 0. 61β — meaning MSCI is approximately 17% more volatile than MORN relative to the S&P 500.
05Which is growing faster — MORN or MSCI?
By revenue growth (latest reported year), MSCI Inc.
(MSCI) is pulling ahead at 9. 7% versus 7. 5% for Morningstar, Inc. (MORN). On earnings-per-share growth, the picture is similar: MSCI Inc. grew EPS 10. 7% year-over-year, compared to 3. 4% for Morningstar, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MORN or MSCI?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus 15. 3% for Morningstar, Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus 21. 5% for MORN. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MORN or MSCI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Morningstar, Inc. (MORN) is the more undervalued stock at a PEG of 1. 24x versus MSCI Inc. 's 1. 75x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Morningstar, Inc. (MORN) trades at 14. 1x forward P/E versus 29. 7x for MSCI Inc. — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MORN: 41. 1% to $236. 50.
08Which pays a better dividend — MORN or MSCI?
All stocks in this comparison pay dividends.
MSCI Inc. (MSCI) offers the highest yield at 1. 2%, versus 1. 1% for Morningstar, Inc. (MORN).
09Is MORN or MSCI better for a retirement portfolio?
For long-horizon retirement investors, MSCI Inc.
(MSCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 61), 1. 2% yield, +723. 8% 10Y return). Both have compounded well over 10 years (MSCI: +723. 8%, MORN: +120. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MORN and MSCI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.